Table of Contents
ISRN Endocrinology
Volume 2011, Article ID 308029, 5 pages
http://dx.doi.org/10.5402/2011/308029
Clinical Study

Analysis of Clinical Outcome of Patients with Poorly Differentiated Thyroid Carcinoma

Department of Breast and Thyroid Surgery, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Japan

Received 17 December 2010; Accepted 6 February 2011

Academic Editor: A. H. Cincotta

Copyright © 2011 Katsuhiro Tanaka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Sakamoto, N. Kasai, and H. Sugano, “Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas,” Cancer, vol. 52, no. 10, pp. 1849–1855, 1983. View at Google Scholar · View at Scopus
  2. M. Sobrinho Simones, M. L. Carcangiu, J. Albores-Saaverdra et al., “Poorly differentiated carcinoma,” in Pathology and Genetics of Tumours of Endocrine Organs, R. A. DeLeillis, R. V. Lloyd, P. U. Heitz, and C. Eng, Eds., pp. 73–76, IARC Press, Lyon, France, 2004. View at Google Scholar
  3. M. Volante, P. Collini, Y. E. Nikiforov et al., “Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach,” American Journal of Surgical Pathology, vol. 31, no. 8, pp. 1256–1264, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M. Decaussin, M. H. Bernard, P. Adeleine et al., “Thyroid carcinomas with distant metastases: a review of 111 cases with emphasis on the prognostic significance of an insular component,” American Journal of Surgical Pathology, vol. 26, no. 8, pp. 1007–1015, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Volante, S. Landolfi, L. Chiusa et al., “Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients,” Cancer, vol. 100, no. 5, pp. 950–957, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. R. Ashfaq, F. Vuitch, R. Delgado, and J. Albores-Saavedra, “Papillary and follicular thyroid carcinomas with an insular component,” Cancer, vol. 73, no. 2, pp. 416–423, 1994. View at Google Scholar · View at Scopus
  7. T. Nishida, S. I. Katayama, M. Tsujimoto, J. I. Nakamura, and H. Matsuda, “Clinicopathological significance of poorly differentiated thyroid carcinoma,” American Journal of Surgical Pathology, vol. 23, no. 2, pp. 205–211, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Shigematsu, H. Takami, and A. Kubo, “Unique treatment policy for well-differentiated thyroid cancer in Japan: results of a questionnaire distributed to members of the Japanese Society of Thyroid Surgery and the International Association of Endocrine Surgeons,” Endocrine Journal, vol. 53, no. 6, pp. 829–839, 2006. View at Publisher · View at Google Scholar
  9. I. Sugitani and Y. Fujimoto, “Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 10, pp. 4576–4583, 2010. View at Publisher · View at Google Scholar · View at PubMed
  10. S. A. Hundahl, I. D. Fleming, A. M. Fremgen, and H. R. Menck, “A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995,” Cancer, vol. 83, no. 12, pp. 2638–2648, 1998. View at Google Scholar · View at Scopus
  11. E. L. Mazzaferri and S. M. Jhiang, “Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer,” American Journal of Medicine, vol. 97, no. 5, pp. 418–428, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. L. J. DeGroot, E. L. Kaplan, F. H. Straus, and M. S. Shukla, “Does the method of management of papillary thyroid carcinoma make a difference in outcome?” World Journal of Surgery, vol. 18, no. 1, pp. 123–130, 1994. View at Google Scholar · View at Scopus
  13. A. M. Sawka, K. Thephamongkhol, M. Brouwers, L. Thabane, G. Browman, and H. C. Gerstein, “A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 8, pp. 3668–3676, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. M. Volante and M. Papotti, “Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours,” Endocrine Pathology, vol. 21, no. 1, pp. 1–6, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. J. D. Lin, T. C. Chao, and C. Hsueh, “Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas,” Clinical Endocrinology, vol. 66, no. 2, pp. 224–228, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. Y. Ito, M. Hirokawa, M. Fukushima et al., “Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan,” World Journal of Surgery, vol. 32, no. 7, pp. 1535–1543, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. G. Pellegriti, D. Giuffrida, C. Scollo et al., “Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis,” Cancer, vol. 95, no. 10, pp. 2076–2085, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. H. Matsumoto, A. Sakamoto, M. Fujiwara et al., “Decreased expression of the thyroid-stimulating hormone receptor in poorly-differentiated carcinoma of the thyroid,” Oncology Reports, vol. 19, no. 6, pp. 1405–1411, 2008. View at Google Scholar · View at Scopus
  19. K. Tanaka, H. Inoue, H. Miki et al., “Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-R,” British Journal of Cancer, vol. 76, no. 5, pp. 594–599, 1997. View at Google Scholar · View at Scopus
  20. N. Fortunati, M. G. Catalano, K. Arena, E. Brignardello, A. Piovesan, and G. Boccuzzi, “Valproic Acid Induces the Expression of the Na/I Symporter and Iodine Uptake in Poorly Differentiated Thyroid Cancer Cells,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 2, pp. 1006–1009, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Furuya, H. Shimura, A. Miyazaki et al., “Adenovirus-mediated transfer of thyroid transcription factor-1 induces radioiodide organification and retention in thyroid cancer cells,” Endocrinology, vol. 145, no. 11, pp. 5397–5405, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus